Cole Pinnow is Chief Commercial Officer of Cogent Biosciences, Inc.. Currently has a direct ownership of 216,650 shares of COGT, which is worth approximately $7.27 Million. The most recent transaction as insider was on Dec 17, 2025, when has been sold 94,800 shares (Common Stock) at a price of $39.45 per share, resulting in proceeds of $3,739,860. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 217K
372.54% 3M change
n/a 12M change
Total Value Held $7.27 Million

Cole Pinnow Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 17 2025
SELL
Payment of exercise price or tax liability
$3,739,860 $39.45 p/Share
94,800 Reduced 30.44%
216,650 Common Stock
Dec 17 2025
BUY
Grant, award, or other acquisition
-
264,000 Added 45.88%
311,450 Common Stock
Jan 14 2025
BUY
Open market or private purchase
$332,500 $7.6 p/Share
43,750 Added 48.83%
45,848 Common Stock
CP

Cole Pinnow

Chief Commercial Officer
Waltham, MA

Track Institutional and Insider Activities on COGT

Follow Cogent Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells COGT shares.

Notify only if

Insider Trading

Get notified when an Cogent Biosciences, Inc. insider buys or sells COGT shares.

Notify only if

News

Receive news related to Cogent Biosciences, Inc.

Track Activities on COGT